nodes	percent_of_prediction	percent_of_DWPC	metapath
Acebutolol—CYP2D6—Niacin—atherosclerosis	0.0978	0.149	CbGbCtD
Acebutolol—ABCB1—Ezetimibe—atherosclerosis	0.0883	0.134	CbGbCtD
Acebutolol—ABCB1—Simvastatin—atherosclerosis	0.0821	0.125	CbGbCtD
Acebutolol—ABCB1—Pravastatin—atherosclerosis	0.0803	0.122	CbGbCtD
Acebutolol—ABCB1—Lovastatin—atherosclerosis	0.0803	0.122	CbGbCtD
Acebutolol—CYP2D6—Simvastatin—atherosclerosis	0.0773	0.118	CbGbCtD
Acebutolol—CYP2D6—Lovastatin—atherosclerosis	0.0757	0.115	CbGbCtD
Acebutolol—CYP2D6—Pravastatin—atherosclerosis	0.0757	0.115	CbGbCtD
Acebutolol—Erectile dysfunction—Lovastatin—atherosclerosis	0.00136	0.00444	CcSEcCtD
Acebutolol—Orthostatic hypotension—Niacin—atherosclerosis	0.00134	0.00437	CcSEcCtD
Acebutolol—Erectile dysfunction—Ezetimibe—atherosclerosis	0.00133	0.00435	CcSEcCtD
Acebutolol—Erectile dysfunction—Simvastatin—atherosclerosis	0.00127	0.00415	CcSEcCtD
Acebutolol—Depression—Simvastatin—atherosclerosis	0.00123	0.00401	CcSEcCtD
Acebutolol—Flatulence—Rosuvastatin—atherosclerosis	0.00119	0.0039	CcSEcCtD
Acebutolol—Erectile dysfunction—Niacin—atherosclerosis	0.00117	0.00381	CcSEcCtD
Acebutolol—Dysuria—Pravastatin—atherosclerosis	0.00117	0.00381	CcSEcCtD
Acebutolol—Pharyngitis—Ezetimibe—atherosclerosis	0.00115	0.00375	CcSEcCtD
Acebutolol—Erectile dysfunction—Pravastatin—atherosclerosis	0.00115	0.00375	CcSEcCtD
Acebutolol—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00114	0.00372	CcSEcCtD
Acebutolol—Weight increased—Pravastatin—atherosclerosis	0.00113	0.00371	CcSEcCtD
Acebutolol—Depression—Pravastatin—atherosclerosis	0.00111	0.00362	CcSEcCtD
Acebutolol—Flushing—Lovastatin—atherosclerosis	0.00109	0.00358	CcSEcCtD
Acebutolol—Sweating—Niacin—atherosclerosis	0.00108	0.00354	CcSEcCtD
Acebutolol—Flushing—Ezetimibe—atherosclerosis	0.00107	0.00351	CcSEcCtD
Acebutolol—Chills—Lovastatin—atherosclerosis	0.00106	0.00346	CcSEcCtD
Acebutolol—Cough—Rosuvastatin—atherosclerosis	0.00106	0.00346	CcSEcCtD
Acebutolol—Angiopathy—Ezetimibe—atherosclerosis	0.00105	0.00343	CcSEcCtD
Acebutolol—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00104	0.00341	CcSEcCtD
Acebutolol—Alopecia—Lovastatin—atherosclerosis	0.00104	0.00341	CcSEcCtD
Acebutolol—Arthralgia—Rosuvastatin—atherosclerosis	0.00103	0.00337	CcSEcCtD
Acebutolol—Myalgia—Rosuvastatin—atherosclerosis	0.00103	0.00337	CcSEcCtD
Acebutolol—Flushing—Simvastatin—atherosclerosis	0.00102	0.00335	CcSEcCtD
Acebutolol—Alopecia—Ezetimibe—atherosclerosis	0.00102	0.00334	CcSEcCtD
Acebutolol—Rhinitis—Niacin—atherosclerosis	0.00102	0.00332	CcSEcCtD
Acebutolol—Flatulence—Lovastatin—atherosclerosis	0.00101	0.00331	CcSEcCtD
Acebutolol—Hypoaesthesia—Niacin—atherosclerosis	0.00101	0.0033	CcSEcCtD
Acebutolol—Rhinitis—Pravastatin—atherosclerosis	0.001	0.00327	CcSEcCtD
Acebutolol—Confusional state—Rosuvastatin—atherosclerosis	0.000997	0.00326	CcSEcCtD
Acebutolol—Back pain—Lovastatin—atherosclerosis	0.000993	0.00325	CcSEcCtD
Acebutolol—Hypoaesthesia—Pravastatin—atherosclerosis	0.000992	0.00325	CcSEcCtD
Acebutolol—Flatulence—Ezetimibe—atherosclerosis	0.000992	0.00325	CcSEcCtD
Acebutolol—Pharyngitis—Pravastatin—atherosclerosis	0.00099	0.00324	CcSEcCtD
Acebutolol—Chills—Simvastatin—atherosclerosis	0.00099	0.00324	CcSEcCtD
Acebutolol—Visual impairment—Niacin—atherosclerosis	0.000976	0.00319	CcSEcCtD
Acebutolol—Alopecia—Simvastatin—atherosclerosis	0.000975	0.00319	CcSEcCtD
Acebutolol—Back pain—Ezetimibe—atherosclerosis	0.000974	0.00319	CcSEcCtD
Acebutolol—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00097	0.00317	CcSEcCtD
Acebutolol—Vision blurred—Lovastatin—atherosclerosis	0.000968	0.00316	CcSEcCtD
Acebutolol—Visual impairment—Pravastatin—atherosclerosis	0.000961	0.00314	CcSEcCtD
Acebutolol—Ill-defined disorder—Lovastatin—atherosclerosis	0.000953	0.00312	CcSEcCtD
Acebutolol—Flatulence—Simvastatin—atherosclerosis	0.000946	0.00309	CcSEcCtD
Acebutolol—Tinnitus—Niacin—atherosclerosis	0.000944	0.00309	CcSEcCtD
Acebutolol—Flushing—Niacin—atherosclerosis	0.00094	0.00307	CcSEcCtD
Acebutolol—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000934	0.00306	CcSEcCtD
Acebutolol—Tinnitus—Pravastatin—atherosclerosis	0.00093	0.00304	CcSEcCtD
Acebutolol—Malaise—Lovastatin—atherosclerosis	0.000926	0.00303	CcSEcCtD
Acebutolol—Flushing—Pravastatin—atherosclerosis	0.000926	0.00303	CcSEcCtD
Acebutolol—Vertigo—Lovastatin—atherosclerosis	0.000922	0.00302	CcSEcCtD
Acebutolol—Angiopathy—Niacin—atherosclerosis	0.000919	0.00301	CcSEcCtD
Acebutolol—Chills—Niacin—atherosclerosis	0.000909	0.00297	CcSEcCtD
Acebutolol—Malaise—Ezetimibe—atherosclerosis	0.000908	0.00297	CcSEcCtD
Acebutolol—Vision blurred—Simvastatin—atherosclerosis	0.000905	0.00296	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000901	0.00295	CcSEcCtD
Acebutolol—Alopecia—Niacin—atherosclerosis	0.000895	0.00293	CcSEcCtD
Acebutolol—Chills—Pravastatin—atherosclerosis	0.000895	0.00293	CcSEcCtD
Acebutolol—Insomnia—Rosuvastatin—atherosclerosis	0.000894	0.00292	CcSEcCtD
Acebutolol—Ill-defined disorder—Simvastatin—atherosclerosis	0.000891	0.00291	CcSEcCtD
Acebutolol—Palpitations—Ezetimibe—atherosclerosis	0.00089	0.00291	CcSEcCtD
Acebutolol—Paraesthesia—Rosuvastatin—atherosclerosis	0.000888	0.0029	CcSEcCtD
Acebutolol—Alopecia—Pravastatin—atherosclerosis	0.000881	0.00288	CcSEcCtD
Acebutolol—Cough—Ezetimibe—atherosclerosis	0.000879	0.00287	CcSEcCtD
Acebutolol—Arthralgia—Lovastatin—atherosclerosis	0.000874	0.00286	CcSEcCtD
Acebutolol—Chest pain—Lovastatin—atherosclerosis	0.000874	0.00286	CcSEcCtD
Acebutolol—Myalgia—Lovastatin—atherosclerosis	0.000874	0.00286	CcSEcCtD
Acebutolol—Anxiety—Lovastatin—atherosclerosis	0.000871	0.00285	CcSEcCtD
Acebutolol—Dyspepsia—Rosuvastatin—atherosclerosis	0.00087	0.00285	CcSEcCtD
Acebutolol—Flatulence—Niacin—atherosclerosis	0.000869	0.00284	CcSEcCtD
Acebutolol—Malaise—Simvastatin—atherosclerosis	0.000866	0.00283	CcSEcCtD
Acebutolol—Discomfort—Lovastatin—atherosclerosis	0.000864	0.00282	CcSEcCtD
Acebutolol—Vertigo—Simvastatin—atherosclerosis	0.000863	0.00282	CcSEcCtD
Acebutolol—Chest pain—Ezetimibe—atherosclerosis	0.000857	0.0028	CcSEcCtD
Acebutolol—Myalgia—Ezetimibe—atherosclerosis	0.000857	0.0028	CcSEcCtD
Acebutolol—Arthralgia—Ezetimibe—atherosclerosis	0.000857	0.0028	CcSEcCtD
Acebutolol—Flatulence—Pravastatin—atherosclerosis	0.000855	0.0028	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000851	0.00278	CcSEcCtD
Acebutolol—Discomfort—Ezetimibe—atherosclerosis	0.000847	0.00277	CcSEcCtD
Acebutolol—Pain—Rosuvastatin—atherosclerosis	0.000845	0.00277	CcSEcCtD
Acebutolol—Constipation—Rosuvastatin—atherosclerosis	0.000845	0.00277	CcSEcCtD
Acebutolol—Confusional state—Lovastatin—atherosclerosis	0.000845	0.00276	CcSEcCtD
Acebutolol—Vision blurred—Niacin—atherosclerosis	0.000831	0.00272	CcSEcCtD
Acebutolol—Confusional state—Ezetimibe—atherosclerosis	0.000829	0.00271	CcSEcCtD
Acebutolol—Vision blurred—Pravastatin—atherosclerosis	0.000818	0.00268	CcSEcCtD
Acebutolol—Chest pain—Simvastatin—atherosclerosis	0.000818	0.00267	CcSEcCtD
Acebutolol—Arthralgia—Simvastatin—atherosclerosis	0.000818	0.00267	CcSEcCtD
Acebutolol—Myalgia—Simvastatin—atherosclerosis	0.000818	0.00267	CcSEcCtD
Acebutolol—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000815	0.00266	CcSEcCtD
Acebutolol—Anxiety—Simvastatin—atherosclerosis	0.000815	0.00266	CcSEcCtD
Acebutolol—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000808	0.00264	CcSEcCtD
Acebutolol—Discomfort—Simvastatin—atherosclerosis	0.000808	0.00264	CcSEcCtD
Acebutolol—Nervous system disorder—Ezetimibe—atherosclerosis	0.000806	0.00264	CcSEcCtD
Acebutolol—Ill-defined disorder—Pravastatin—atherosclerosis	0.000806	0.00263	CcSEcCtD
Acebutolol—Anorexia—Lovastatin—atherosclerosis	0.000799	0.00261	CcSEcCtD
Acebutolol—Skin disorder—Ezetimibe—atherosclerosis	0.000798	0.00261	CcSEcCtD
Acebutolol—Vertigo—Niacin—atherosclerosis	0.000792	0.00259	CcSEcCtD
Acebutolol—Syncope—Niacin—atherosclerosis	0.000791	0.00259	CcSEcCtD
Acebutolol—Confusional state—Simvastatin—atherosclerosis	0.00079	0.00258	CcSEcCtD
Acebutolol—Urticaria—Rosuvastatin—atherosclerosis	0.000785	0.00257	CcSEcCtD
Acebutolol—Oedema—Simvastatin—atherosclerosis	0.000784	0.00256	CcSEcCtD
Acebutolol—Malaise—Pravastatin—atherosclerosis	0.000783	0.00256	CcSEcCtD
Acebutolol—Abdominal pain—Rosuvastatin—atherosclerosis	0.000782	0.00256	CcSEcCtD
Acebutolol—Vertigo—Pravastatin—atherosclerosis	0.00078	0.00255	CcSEcCtD
Acebutolol—Palpitations—Niacin—atherosclerosis	0.000779	0.00255	CcSEcCtD
Acebutolol—Loss of consciousness—Niacin—atherosclerosis	0.000775	0.00253	CcSEcCtD
Acebutolol—Cough—Niacin—atherosclerosis	0.000769	0.00252	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000763	0.0025	CcSEcCtD
Acebutolol—Insomnia—Lovastatin—atherosclerosis	0.000758	0.00248	CcSEcCtD
Acebutolol—Cough—Pravastatin—atherosclerosis	0.000758	0.00248	CcSEcCtD
Acebutolol—Paraesthesia—Lovastatin—atherosclerosis	0.000752	0.00246	CcSEcCtD
Acebutolol—Myalgia—Niacin—atherosclerosis	0.000751	0.00246	CcSEcCtD
Acebutolol—Arthralgia—Niacin—atherosclerosis	0.000751	0.00246	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000749	0.00245	CcSEcCtD
Acebutolol—Anorexia—Simvastatin—atherosclerosis	0.000747	0.00244	CcSEcCtD
Acebutolol—Dyspnoea—Lovastatin—atherosclerosis	0.000747	0.00244	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000745	0.00244	CcSEcCtD
Acebutolol—Insomnia—Ezetimibe—atherosclerosis	0.000743	0.00243	CcSEcCtD
Acebutolol—Chest pain—Pravastatin—atherosclerosis	0.000739	0.00242	CcSEcCtD
Acebutolol—Arthralgia—Pravastatin—atherosclerosis	0.000739	0.00242	CcSEcCtD
Acebutolol—Myalgia—Pravastatin—atherosclerosis	0.000739	0.00242	CcSEcCtD
Acebutolol—Paraesthesia—Ezetimibe—atherosclerosis	0.000738	0.00241	CcSEcCtD
Acebutolol—Dyspepsia—Lovastatin—atherosclerosis	0.000738	0.00241	CcSEcCtD
Acebutolol—Anxiety—Pravastatin—atherosclerosis	0.000737	0.00241	CcSEcCtD
Acebutolol—Dyspnoea—Ezetimibe—atherosclerosis	0.000733	0.0024	CcSEcCtD
Acebutolol—Discomfort—Pravastatin—atherosclerosis	0.00073	0.00239	CcSEcCtD
Acebutolol—Decreased appetite—Lovastatin—atherosclerosis	0.000728	0.00238	CcSEcCtD
Acebutolol—Dyspepsia—Ezetimibe—atherosclerosis	0.000723	0.00237	CcSEcCtD
Acebutolol—Fatigue—Lovastatin—atherosclerosis	0.000722	0.00236	CcSEcCtD
Acebutolol—Oedema—Niacin—atherosclerosis	0.00072	0.00235	CcSEcCtD
Acebutolol—Constipation—Lovastatin—atherosclerosis	0.000716	0.00234	CcSEcCtD
Acebutolol—Pain—Lovastatin—atherosclerosis	0.000716	0.00234	CcSEcCtD
Acebutolol—Confusional state—Pravastatin—atherosclerosis	0.000714	0.00234	CcSEcCtD
Acebutolol—Decreased appetite—Ezetimibe—atherosclerosis	0.000714	0.00234	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000714	0.00234	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000709	0.00232	CcSEcCtD
Acebutolol—Asthenia—Rosuvastatin—atherosclerosis	0.000709	0.00232	CcSEcCtD
Acebutolol—Insomnia—Simvastatin—atherosclerosis	0.000709	0.00232	CcSEcCtD
Acebutolol—Oedema—Pravastatin—atherosclerosis	0.000709	0.00232	CcSEcCtD
Acebutolol—Fatigue—Ezetimibe—atherosclerosis	0.000709	0.00232	CcSEcCtD
Acebutolol—Shock—Niacin—atherosclerosis	0.000708	0.00232	CcSEcCtD
Acebutolol—Paraesthesia—Simvastatin—atherosclerosis	0.000704	0.0023	CcSEcCtD
Acebutolol—Constipation—Ezetimibe—atherosclerosis	0.000703	0.0023	CcSEcCtD
Acebutolol—Pain—Ezetimibe—atherosclerosis	0.000703	0.0023	CcSEcCtD
Acebutolol—Pruritus—Rosuvastatin—atherosclerosis	0.000699	0.00229	CcSEcCtD
Acebutolol—Skin disorder—Niacin—atherosclerosis	0.000699	0.00229	CcSEcCtD
Acebutolol—Dyspnoea—Simvastatin—atherosclerosis	0.000699	0.00229	CcSEcCtD
Acebutolol—Hyperhidrosis—Niacin—atherosclerosis	0.000696	0.00228	CcSEcCtD
Acebutolol—Feeling abnormal—Lovastatin—atherosclerosis	0.00069	0.00226	CcSEcCtD
Acebutolol—Dyspepsia—Simvastatin—atherosclerosis	0.00069	0.00226	CcSEcCtD
Acebutolol—Anorexia—Niacin—atherosclerosis	0.000686	0.00224	CcSEcCtD
Acebutolol—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000685	0.00224	CcSEcCtD
Acebutolol—Hyperhidrosis—Pravastatin—atherosclerosis	0.000685	0.00224	CcSEcCtD
Acebutolol—Decreased appetite—Simvastatin—atherosclerosis	0.000681	0.00223	CcSEcCtD
Acebutolol—Feeling abnormal—Ezetimibe—atherosclerosis	0.000677	0.00221	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000677	0.00221	CcSEcCtD
Acebutolol—Diarrhoea—Rosuvastatin—atherosclerosis	0.000676	0.00221	CcSEcCtD
Acebutolol—Fatigue—Simvastatin—atherosclerosis	0.000676	0.00221	CcSEcCtD
Acebutolol—Anorexia—Pravastatin—atherosclerosis	0.000675	0.00221	CcSEcCtD
Acebutolol—Hypotension—Niacin—atherosclerosis	0.000672	0.0022	CcSEcCtD
Acebutolol—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000672	0.0022	CcSEcCtD
Acebutolol—Pain—Simvastatin—atherosclerosis	0.00067	0.00219	CcSEcCtD
Acebutolol—Constipation—Simvastatin—atherosclerosis	0.00067	0.00219	CcSEcCtD
Acebutolol—Urticaria—Lovastatin—atherosclerosis	0.000666	0.00218	CcSEcCtD
Acebutolol—Body temperature increased—Lovastatin—atherosclerosis	0.000662	0.00217	CcSEcCtD
Acebutolol—Abdominal pain—Lovastatin—atherosclerosis	0.000662	0.00217	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000656	0.00214	CcSEcCtD
Acebutolol—Dizziness—Rosuvastatin—atherosclerosis	0.000654	0.00214	CcSEcCtD
Acebutolol—Urticaria—Ezetimibe—atherosclerosis	0.000653	0.00214	CcSEcCtD
Acebutolol—Insomnia—Niacin—atherosclerosis	0.000651	0.00213	CcSEcCtD
Acebutolol—Abdominal pain—Ezetimibe—atherosclerosis	0.00065	0.00212	CcSEcCtD
Acebutolol—Body temperature increased—Ezetimibe—atherosclerosis	0.00065	0.00212	CcSEcCtD
Acebutolol—Paraesthesia—Niacin—atherosclerosis	0.000646	0.00211	CcSEcCtD
Acebutolol—Feeling abnormal—Simvastatin—atherosclerosis	0.000646	0.00211	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000646	0.00211	CcSEcCtD
Acebutolol—Dyspnoea—Niacin—atherosclerosis	0.000642	0.0021	CcSEcCtD
Acebutolol—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000641	0.0021	CcSEcCtD
Acebutolol—Insomnia—Pravastatin—atherosclerosis	0.000641	0.0021	CcSEcCtD
Acebutolol—Somnolence—Niacin—atherosclerosis	0.00064	0.00209	CcSEcCtD
Acebutolol—Paraesthesia—Pravastatin—atherosclerosis	0.000636	0.00208	CcSEcCtD
Acebutolol—Dyspepsia—Niacin—atherosclerosis	0.000633	0.00207	CcSEcCtD
Acebutolol—Dyspnoea—Pravastatin—atherosclerosis	0.000632	0.00207	CcSEcCtD
Acebutolol—Decreased appetite—Niacin—atherosclerosis	0.000626	0.00205	CcSEcCtD
Acebutolol—Dyspepsia—Pravastatin—atherosclerosis	0.000624	0.00204	CcSEcCtD
Acebutolol—Rash—Rosuvastatin—atherosclerosis	0.000623	0.00204	CcSEcCtD
Acebutolol—Dermatitis—Rosuvastatin—atherosclerosis	0.000623	0.00204	CcSEcCtD
Acebutolol—Urticaria—Simvastatin—atherosclerosis	0.000623	0.00204	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Niacin—atherosclerosis	0.000621	0.00203	CcSEcCtD
Acebutolol—Abdominal pain—Simvastatin—atherosclerosis	0.00062	0.00203	CcSEcCtD
Acebutolol—Body temperature increased—Simvastatin—atherosclerosis	0.00062	0.00203	CcSEcCtD
Acebutolol—Headache—Rosuvastatin—atherosclerosis	0.000619	0.00203	CcSEcCtD
Acebutolol—Decreased appetite—Pravastatin—atherosclerosis	0.000616	0.00201	CcSEcCtD
Acebutolol—Pain—Niacin—atherosclerosis	0.000615	0.00201	CcSEcCtD
Acebutolol—Fatigue—Pravastatin—atherosclerosis	0.000611	0.002	CcSEcCtD
Acebutolol—Pain—Pravastatin—atherosclerosis	0.000606	0.00198	CcSEcCtD
Acebutolol—Constipation—Pravastatin—atherosclerosis	0.000606	0.00198	CcSEcCtD
Acebutolol—Asthenia—Lovastatin—atherosclerosis	0.000601	0.00197	CcSEcCtD
Acebutolol—Pruritus—Lovastatin—atherosclerosis	0.000593	0.00194	CcSEcCtD
Acebutolol—Asthenia—Ezetimibe—atherosclerosis	0.00059	0.00193	CcSEcCtD
Acebutolol—Gastrointestinal pain—Niacin—atherosclerosis	0.000588	0.00192	CcSEcCtD
Acebutolol—Nausea—Rosuvastatin—atherosclerosis	0.000587	0.00192	CcSEcCtD
Acebutolol—Feeling abnormal—Pravastatin—atherosclerosis	0.000584	0.00191	CcSEcCtD
Acebutolol—Pruritus—Ezetimibe—atherosclerosis	0.000581	0.0019	CcSEcCtD
Acebutolol—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000579	0.00189	CcSEcCtD
Acebutolol—Diarrhoea—Lovastatin—atherosclerosis	0.000573	0.00187	CcSEcCtD
Acebutolol—Urticaria—Niacin—atherosclerosis	0.000572	0.00187	CcSEcCtD
Acebutolol—Abdominal pain—Niacin—atherosclerosis	0.000569	0.00186	CcSEcCtD
Acebutolol—Body temperature increased—Niacin—atherosclerosis	0.000569	0.00186	CcSEcCtD
Acebutolol—Urticaria—Pravastatin—atherosclerosis	0.000563	0.00184	CcSEcCtD
Acebutolol—Asthenia—Simvastatin—atherosclerosis	0.000562	0.00184	CcSEcCtD
Acebutolol—Diarrhoea—Ezetimibe—atherosclerosis	0.000562	0.00184	CcSEcCtD
Acebutolol—Body temperature increased—Pravastatin—atherosclerosis	0.00056	0.00183	CcSEcCtD
Acebutolol—Abdominal pain—Pravastatin—atherosclerosis	0.00056	0.00183	CcSEcCtD
Acebutolol—Pruritus—Simvastatin—atherosclerosis	0.000554	0.00181	CcSEcCtD
Acebutolol—Dizziness—Lovastatin—atherosclerosis	0.000554	0.00181	CcSEcCtD
Acebutolol—Dizziness—Ezetimibe—atherosclerosis	0.000543	0.00178	CcSEcCtD
Acebutolol—Diarrhoea—Simvastatin—atherosclerosis	0.000536	0.00175	CcSEcCtD
Acebutolol—Vomiting—Lovastatin—atherosclerosis	0.000533	0.00174	CcSEcCtD
Acebutolol—Rash—Lovastatin—atherosclerosis	0.000528	0.00173	CcSEcCtD
Acebutolol—Dermatitis—Lovastatin—atherosclerosis	0.000528	0.00173	CcSEcCtD
Acebutolol—Headache—Lovastatin—atherosclerosis	0.000525	0.00172	CcSEcCtD
Acebutolol—Vomiting—Ezetimibe—atherosclerosis	0.000523	0.00171	CcSEcCtD
Acebutolol—Dizziness—Simvastatin—atherosclerosis	0.000518	0.00169	CcSEcCtD
Acebutolol—Rash—Ezetimibe—atherosclerosis	0.000518	0.00169	CcSEcCtD
Acebutolol—Dermatitis—Ezetimibe—atherosclerosis	0.000518	0.00169	CcSEcCtD
Acebutolol—Asthenia—Niacin—atherosclerosis	0.000516	0.00169	CcSEcCtD
Acebutolol—Headache—Ezetimibe—atherosclerosis	0.000515	0.00168	CcSEcCtD
Acebutolol—Pruritus—Niacin—atherosclerosis	0.000509	0.00167	CcSEcCtD
Acebutolol—Asthenia—Pravastatin—atherosclerosis	0.000508	0.00166	CcSEcCtD
Acebutolol—Pruritus—Pravastatin—atherosclerosis	0.000501	0.00164	CcSEcCtD
Acebutolol—Vomiting—Simvastatin—atherosclerosis	0.000498	0.00163	CcSEcCtD
Acebutolol—Nausea—Lovastatin—atherosclerosis	0.000498	0.00163	CcSEcCtD
Acebutolol—Rash—Simvastatin—atherosclerosis	0.000494	0.00162	CcSEcCtD
Acebutolol—Dermatitis—Simvastatin—atherosclerosis	0.000494	0.00161	CcSEcCtD
Acebutolol—Diarrhoea—Niacin—atherosclerosis	0.000492	0.00161	CcSEcCtD
Acebutolol—Headache—Simvastatin—atherosclerosis	0.000491	0.00161	CcSEcCtD
Acebutolol—Nausea—Ezetimibe—atherosclerosis	0.000488	0.0016	CcSEcCtD
Acebutolol—Diarrhoea—Pravastatin—atherosclerosis	0.000485	0.00159	CcSEcCtD
Acebutolol—Dizziness—Niacin—atherosclerosis	0.000476	0.00156	CcSEcCtD
Acebutolol—Dizziness—Pravastatin—atherosclerosis	0.000469	0.00153	CcSEcCtD
Acebutolol—Nausea—Simvastatin—atherosclerosis	0.000466	0.00152	CcSEcCtD
Acebutolol—Vomiting—Niacin—atherosclerosis	0.000458	0.0015	CcSEcCtD
Acebutolol—Rash—Niacin—atherosclerosis	0.000454	0.00148	CcSEcCtD
Acebutolol—Dermatitis—Niacin—atherosclerosis	0.000453	0.00148	CcSEcCtD
Acebutolol—Headache—Niacin—atherosclerosis	0.000451	0.00147	CcSEcCtD
Acebutolol—Vomiting—Pravastatin—atherosclerosis	0.00045	0.00147	CcSEcCtD
Acebutolol—Rash—Pravastatin—atherosclerosis	0.000447	0.00146	CcSEcCtD
Acebutolol—Dermatitis—Pravastatin—atherosclerosis	0.000446	0.00146	CcSEcCtD
Acebutolol—Headache—Pravastatin—atherosclerosis	0.000444	0.00145	CcSEcCtD
Acebutolol—Nausea—Niacin—atherosclerosis	0.000427	0.0014	CcSEcCtD
Acebutolol—Nausea—Pravastatin—atherosclerosis	0.000421	0.00138	CcSEcCtD
Acebutolol—ADRB1—Signaling by GPCR—CCL5—atherosclerosis	2.64e-05	0.000716	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—APOC3—atherosclerosis	2.63e-05	0.000714	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—LDLR—atherosclerosis	2.62e-05	0.00071	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—EDN1—atherosclerosis	2.6e-05	0.000706	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CCL5—atherosclerosis	2.58e-05	0.0007	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ABCG1—atherosclerosis	2.58e-05	0.0007	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CETP—atherosclerosis	2.56e-05	0.000693	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	2.54e-05	0.000689	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—PRKCG—atherosclerosis	2.51e-05	0.000681	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—VWF—atherosclerosis	2.5e-05	0.000678	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	2.5e-05	0.000677	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—APOC3—atherosclerosis	2.48e-05	0.000673	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—LDLR—atherosclerosis	2.47e-05	0.000669	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PRKCG—atherosclerosis	2.46e-05	0.000666	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—SCARB1—atherosclerosis	2.45e-05	0.000664	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—VWF—atherosclerosis	2.44e-05	0.000663	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—AGT—atherosclerosis	2.43e-05	0.000659	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ABCG1—atherosclerosis	2.43e-05	0.000659	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—APOC3—atherosclerosis	2.43e-05	0.000659	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—FABP4—atherosclerosis	2.43e-05	0.000658	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—LCAT—atherosclerosis	2.43e-05	0.000658	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—LDLR—atherosclerosis	2.41e-05	0.000655	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CCL3—atherosclerosis	2.41e-05	0.000654	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	2.4e-05	0.00065	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—APOA4—atherosclerosis	2.38e-05	0.000646	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—AGT—atherosclerosis	2.38e-05	0.000645	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CCL3—atherosclerosis	2.36e-05	0.000639	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYP7A1—atherosclerosis	2.34e-05	0.000634	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—HMGCR—atherosclerosis	2.31e-05	0.000627	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NCF1—atherosclerosis	2.31e-05	0.000626	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	2.31e-05	0.000625	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—FABP4—atherosclerosis	2.29e-05	0.00062	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—LCAT—atherosclerosis	2.29e-05	0.00062	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—ALB—atherosclerosis	2.27e-05	0.000615	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NCF1—atherosclerosis	2.26e-05	0.000612	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—F2—atherosclerosis	2.25e-05	0.000609	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—APOA4—atherosclerosis	2.24e-05	0.000608	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	2.21e-05	0.0006	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—AGT—atherosclerosis	2.21e-05	0.000599	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CYP7A1—atherosclerosis	2.2e-05	0.000598	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—F2—atherosclerosis	2.2e-05	0.000596	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	2.18e-05	0.000592	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CCR2—atherosclerosis	2.18e-05	0.000591	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—EDNRA—atherosclerosis	2.18e-05	0.000591	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CYBA—atherosclerosis	2.17e-05	0.000589	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYP27A1—atherosclerosis	2.16e-05	0.000586	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—AGT—atherosclerosis	2.16e-05	0.000586	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—PIK3CG—atherosclerosis	2.15e-05	0.000583	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—EDNRA—atherosclerosis	2.13e-05	0.000578	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CCR2—atherosclerosis	2.13e-05	0.000578	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—GHRL—atherosclerosis	2.12e-05	0.000576	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PLAT—atherosclerosis	2.12e-05	0.000576	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PARP1—atherosclerosis	2.12e-05	0.000576	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CYBA—atherosclerosis	2.12e-05	0.000576	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	2.12e-05	0.000575	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	2.12e-05	0.000574	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—PIK3CG—atherosclerosis	2.1e-05	0.00057	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PARP1—atherosclerosis	2.08e-05	0.000564	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PLAT—atherosclerosis	2.08e-05	0.000564	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—GHRL—atherosclerosis	2.08e-05	0.000564	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—ABCA1—atherosclerosis	2.06e-05	0.000559	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ALOX15—atherosclerosis	2.05e-05	0.000556	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PLA2G2A—atherosclerosis	2.05e-05	0.000556	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ALOX5AP—atherosclerosis	2.05e-05	0.000556	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—APOA2—atherosclerosis	2.05e-05	0.000556	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—F2—atherosclerosis	2.04e-05	0.000553	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CYP27A1—atherosclerosis	2.04e-05	0.000553	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ABCG5—atherosclerosis	2.02e-05	0.000549	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—F2—atherosclerosis	2e-05	0.000541	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	1.98e-05	0.000536	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—LPA—atherosclerosis	1.96e-05	0.00053	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—PIK3CG—atherosclerosis	1.95e-05	0.000529	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	1.93e-05	0.000524	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ALOX15—atherosclerosis	1.93e-05	0.000524	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—APOA2—atherosclerosis	1.93e-05	0.000524	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	1.93e-05	0.000524	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PIK3CG—atherosclerosis	1.91e-05	0.000518	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ABCG5—atherosclerosis	1.91e-05	0.000517	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—BGN—atherosclerosis	1.89e-05	0.000514	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—APOA5—atherosclerosis	1.87e-05	0.000508	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—KNG1—atherosclerosis	1.86e-05	0.000506	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—AGTR1—atherosclerosis	1.85e-05	0.000503	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—LPA—atherosclerosis	1.84e-05	0.0005	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—KNG1—atherosclerosis	1.82e-05	0.000495	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—CCL2—atherosclerosis	1.82e-05	0.000493	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—AGTR1—atherosclerosis	1.81e-05	0.000492	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PLG—atherosclerosis	1.81e-05	0.00049	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PLA2G1B—atherosclerosis	1.8e-05	0.000489	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.79e-05	0.000485	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—BGN—atherosclerosis	1.78e-05	0.000484	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CCL2—atherosclerosis	1.78e-05	0.000482	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—HMOX1—atherosclerosis	1.77e-05	0.00048	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PLG—atherosclerosis	1.77e-05	0.000479	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—APOA5—atherosclerosis	1.77e-05	0.000479	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ALOX5—atherosclerosis	1.74e-05	0.000473	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—SOCS3—atherosclerosis	1.71e-05	0.000464	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	1.7e-05	0.000461	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—APOB—atherosclerosis	1.69e-05	0.000459	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.68e-05	0.000455	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—SOCS3—atherosclerosis	1.67e-05	0.000454	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MMP3—atherosclerosis	1.65e-05	0.000448	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—GSTM1—atherosclerosis	1.65e-05	0.000447	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IGF2—atherosclerosis	1.64e-05	0.000446	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ALOX5—atherosclerosis	1.64e-05	0.000445	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—LPL—atherosclerosis	1.62e-05	0.000439	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MMP3—atherosclerosis	1.62e-05	0.000438	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IGF2—atherosclerosis	1.61e-05	0.000436	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—APOB—atherosclerosis	1.6e-05	0.000433	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—CXCL8—atherosclerosis	1.58e-05	0.000429	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—GPX1—atherosclerosis	1.58e-05	0.000428	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—EDN1—atherosclerosis	1.57e-05	0.000426	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—NAMPT—atherosclerosis	1.56e-05	0.000424	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—APOB—atherosclerosis	1.56e-05	0.000424	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CCL5—atherosclerosis	1.56e-05	0.000423	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—LIPC—atherosclerosis	1.55e-05	0.000421	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—CXCL8—atherosclerosis	1.55e-05	0.00042	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—APOC3—atherosclerosis	1.54e-05	0.000419	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—EDN1—atherosclerosis	1.54e-05	0.000417	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CD36—atherosclerosis	1.54e-05	0.000417	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—LDLR—atherosclerosis	1.53e-05	0.000416	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CCL5—atherosclerosis	1.53e-05	0.000414	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—LPL—atherosclerosis	1.52e-05	0.000413	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CETP—atherosclerosis	1.5e-05	0.000406	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—LPL—atherosclerosis	1.49e-05	0.000404	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PRKCG—atherosclerosis	1.48e-05	0.000402	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.47e-05	0.000399	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.47e-05	0.000399	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—LIPC—atherosclerosis	1.46e-05	0.000397	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—MTHFR—atherosclerosis	1.46e-05	0.000395	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—APOC3—atherosclerosis	1.45e-05	0.000395	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PRKCG—atherosclerosis	1.45e-05	0.000393	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—LDLR—atherosclerosis	1.45e-05	0.000392	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—SPP1—atherosclerosis	1.44e-05	0.000392	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—CXCL8—atherosclerosis	1.44e-05	0.00039	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—SCARB1—atherosclerosis	1.44e-05	0.000389	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PPARA—atherosclerosis	1.43e-05	0.000387	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—SPP1—atherosclerosis	1.41e-05	0.000383	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CETP—atherosclerosis	1.41e-05	0.000383	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CXCL8—atherosclerosis	1.41e-05	0.000381	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—AGT—atherosclerosis	1.38e-05	0.000375	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—APOE—atherosclerosis	1.36e-05	0.000368	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—HMGCR—atherosclerosis	1.36e-05	0.000368	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.35e-05	0.000367	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CAV1—atherosclerosis	1.34e-05	0.000364	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—APOA1—atherosclerosis	1.34e-05	0.000363	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PDGFB—atherosclerosis	1.34e-05	0.000362	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.33e-05	0.00036	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PDGFB—atherosclerosis	1.31e-05	0.000354	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—AGT—atherosclerosis	1.3e-05	0.000354	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—LEP—atherosclerosis	1.28e-05	0.000347	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—APOE—atherosclerosis	1.28e-05	0.000347	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.28e-05	0.000346	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—AGT—atherosclerosis	1.28e-05	0.000346	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CAV1—atherosclerosis	1.27e-05	0.000343	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—APOA1—atherosclerosis	1.26e-05	0.000343	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—LEP—atherosclerosis	1.25e-05	0.000339	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—APOE—atherosclerosis	1.25e-05	0.000339	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CAV1—atherosclerosis	1.24e-05	0.000336	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—APOA1—atherosclerosis	1.24e-05	0.000335	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PIK3CG—atherosclerosis	1.22e-05	0.000332	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—ESR1—atherosclerosis	1.22e-05	0.000331	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ABCA1—atherosclerosis	1.21e-05	0.000328	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—F2—atherosclerosis	1.21e-05	0.000327	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—ESR1—atherosclerosis	1.19e-05	0.000324	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PPARG—atherosclerosis	1.18e-05	0.00032	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—F2—atherosclerosis	1.18e-05	0.00032	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—INS—atherosclerosis	1.16e-05	0.000314	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PIK3CG—atherosclerosis	1.15e-05	0.000313	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ABCA1—atherosclerosis	1.14e-05	0.000309	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PIK3CG—atherosclerosis	1.13e-05	0.000306	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—MAPK3—atherosclerosis	1.1e-05	0.0003	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—INS—atherosclerosis	1.09e-05	0.000296	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—MAPK3—atherosclerosis	1.08e-05	0.000293	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CCL2—atherosclerosis	1.07e-05	0.000291	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—INS—atherosclerosis	1.07e-05	0.00029	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—ALB—atherosclerosis	1.06e-05	0.000288	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IGF1—atherosclerosis	1.06e-05	0.000286	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CCL2—atherosclerosis	1.05e-05	0.000285	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—HMOX1—atherosclerosis	1.04e-05	0.000281	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IGF1—atherosclerosis	1.03e-05	0.00028	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—NOS3—atherosclerosis	1.02e-05	0.000275	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—SERPINE1—atherosclerosis	1e-05	0.000272	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—APOB—atherosclerosis	9.93e-06	0.000269	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—SERPINE1—atherosclerosis	9.81e-06	0.000266	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—HMOX1—atherosclerosis	9.77e-06	0.000265	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GSTM1—atherosclerosis	9.66e-06	0.000262	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NOS3—atherosclerosis	9.58e-06	0.00026	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—LPL—atherosclerosis	9.48e-06	0.000257	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NOS3—atherosclerosis	9.37e-06	0.000254	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—APOB—atherosclerosis	9.36e-06	0.000254	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PTGS2—atherosclerosis	9.29e-06	0.000252	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GPX1—atherosclerosis	9.25e-06	0.000251	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GSTM1—atherosclerosis	9.1e-06	0.000247	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CD36—atherosclerosis	9.01e-06	0.000244	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—LPL—atherosclerosis	8.93e-06	0.000242	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GPX1—atherosclerosis	8.72e-06	0.000236	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—MTHFR—atherosclerosis	8.54e-06	0.000231	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CXCL8—atherosclerosis	8.49e-06	0.00023	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CD36—atherosclerosis	8.49e-06	0.00023	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PPARA—atherosclerosis	8.37e-06	0.000227	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CXCL8—atherosclerosis	8.31e-06	0.000225	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—AKT1—atherosclerosis	8.21e-06	0.000222	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—AGT—atherosclerosis	8.11e-06	0.00022	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—IL6—atherosclerosis	8.08e-06	0.000219	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—MTHFR—atherosclerosis	8.04e-06	0.000218	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—AKT1—atherosclerosis	8.03e-06	0.000218	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—APOE—atherosclerosis	7.95e-06	0.000215	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—IL6—atherosclerosis	7.9e-06	0.000214	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PPARA—atherosclerosis	7.89e-06	0.000214	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CAV1—atherosclerosis	7.87e-06	0.000213	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—APOA1—atherosclerosis	7.86e-06	0.000213	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MMP9—atherosclerosis	7.68e-06	0.000208	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—AGT—atherosclerosis	7.64e-06	0.000207	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NFKB1—atherosclerosis	7.6e-06	0.000206	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MMP9—atherosclerosis	7.52e-06	0.000204	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—APOE—atherosclerosis	7.49e-06	0.000203	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MAPK8—atherosclerosis	7.47e-06	0.000203	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—AKT1—atherosclerosis	7.45e-06	0.000202	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NFKB1—atherosclerosis	7.44e-06	0.000202	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CAV1—atherosclerosis	7.42e-06	0.000201	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—APOA1—atherosclerosis	7.4e-06	0.000201	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MAPK8—atherosclerosis	7.31e-06	0.000198	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—AKT1—atherosclerosis	7.29e-06	0.000198	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PIK3CG—atherosclerosis	7.17e-06	0.000194	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PPARG—atherosclerosis	6.92e-06	0.000188	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—VEGFA—atherosclerosis	6.9e-06	0.000187	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—STAT3—atherosclerosis	6.83e-06	0.000185	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—INS—atherosclerosis	6.79e-06	0.000184	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PIK3CG—atherosclerosis	6.76e-06	0.000183	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—VEGFA—atherosclerosis	6.75e-06	0.000183	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—STAT3—atherosclerosis	6.68e-06	0.000181	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MAPK3—atherosclerosis	6.53e-06	0.000177	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PPARG—atherosclerosis	6.52e-06	0.000177	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—INS—atherosclerosis	6.4e-06	0.000173	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MAPK3—atherosclerosis	6.38e-06	0.000173	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TGFB1—atherosclerosis	6.33e-06	0.000172	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ALB—atherosclerosis	6.22e-06	0.000169	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TGFB1—atherosclerosis	6.19e-06	0.000168	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—NOS3—atherosclerosis	5.95e-06	0.000161	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ALB—atherosclerosis	5.86e-06	0.000159	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—NOS3—atherosclerosis	5.61e-06	0.000152	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PTGS2—atherosclerosis	5.44e-06	0.000148	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PTGS2—atherosclerosis	5.13e-06	0.000139	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IL6—atherosclerosis	4.77e-06	0.000129	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—AKT1—atherosclerosis	4.67e-06	0.000127	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IL6—atherosclerosis	4.67e-06	0.000127	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—AKT1—atherosclerosis	4.4e-06	0.000119	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—AKT1—atherosclerosis	4.31e-06	0.000117	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—AKT1—atherosclerosis	2.74e-06	7.42e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—AKT1—atherosclerosis	2.58e-06	6.99e-05	CbGpPWpGaD
